Atlas Trials

IO Biotech

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch IO Biotech

RecordFirmDate
IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18) (NCT05155254)IO Biotech2022-05-17
IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC (NCT05077709)IO Biotech2022-04-11
IO102 With Pembrolizumab, With or Without Chemotherapy, as First-line Treatment of Metastatic NSCLC (NCT03562871)IO Biotech2018-08-22

Track IO Biotech automatically

Every clearance here is in the API, with alerts when new ones post.